Literature DB >> 8686529

Increase of interleukin-6 plasma levels after elective craniotomy: influence of interleukin-10 and catecholamines.

M Heesen1, W Deinsberger, G V Dietrich, O Detsch, J Boldt, G Hempelmann.   

Abstract

Accidental and operative trauma are able to induce a systemic reaction of the organism characterized by fever, leukocytosis, catabolism, and an activation of the coagulation system. Interleukin-6 (IL-6) has been found to be an important mediator of this acute-phase response. In this study the influence of elective craniotomy on IL-6 plasma levels was evaluated. Blood samples were obtained from 20 patients undergoing elective craniotomy for vascular or tumorous diseases of the brain. IL-6 increased significantly (p < 0.05) from the pre-operative (0(0-5.4) pg/ml) to the intraoperative (180 min after beginning of surgery) time-point (10.6 (0-18.5) pg/ml). The maximum was reached on the first postoperative morning (13.9(4.3-45.0) pg/ml). Interleukin-10 (IL-10) is an anti-inflammatory cytokine which suppresses IL-6 synthesis in vitro in various cell lines. IL-10 plasma concentrations showed no alterations throughout the study period. Epinephrine plasma concentrations increased significantly from pre-operative values (15 (0-74) pg/ml) to the postoperative time-point (57(9-459) pg/ml). A 4.5-fold increase (p < 0.05) of norepinephrine plasma concentrations was found when comparing the data obtained 60 min after beginning of surgery with the data of the first postoperative morning. In monocytes, which are a major source of plasma IL-6, an elevation of intracellular cAMP stimulates the IL-6 synthesis. The postoperative maximum of IL-6 in plasma could be due to a release of catecholamines. In conclusion this study demonstrated an elevation of IL-6 plasma concentrations during and after elective craniotomy. Increased plasma catecholamine concentrations as well as a damage in the blood-brain barrier due to the surgical trauma with a spill-over of IL-6 from brain tissue into plasma could have contributed to this result.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8686529     DOI: 10.1007/bf01411728

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  28 in total

1.  Distinct roles of IL-1 and IL-6 in human T cell activation.

Authors:  F A Houssiau; P G Coulie; J Van Snick
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

2.  Serum levels of interleukin-6 and acute phase responses.

Authors:  M W Nijsten; E R de Groot; H J ten Duis; H J Klasen; C E Hack; L A Aarden
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

3.  Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells.

Authors:  P K Peterson; B Sharp; G Gekker; C Brummitt; W F Keane
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

4.  Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.

Authors:  H F Starnes; M K Pearce; A Tewari; J H Yim; J C Zou; J S Abrams
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

Review 5.  [Immunologic monitoring after severe trauma].

Authors:  W Ertel; E Faist
Journal:  Unfallchirurg       Date:  1993-04       Impact factor: 1.000

6.  Traumatic injury induces interleukin-6 production by human astrocytes.

Authors:  R J Hariri; V A Chang; P S Barie; R S Wang; S F Sharif; J B Ghajar
Journal:  Brain Res       Date:  1994-02-04       Impact factor: 3.252

7.  Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage.

Authors:  T Mathiesen; B Andersson; A Loftenius; H von Holst
Journal:  J Neurosurg       Date:  1993-04       Impact factor: 5.115

8.  Secretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growth.

Authors:  T Todo; E F Adams; B Rafferty; R Fahlbusch; T Dingermann; H Werner
Journal:  J Neurosurg       Date:  1994-09       Impact factor: 5.115

9.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

10.  Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage.

Authors:  A Ayala; P Wang; Z F Ba; M M Perrin; W Ertel; I H Chaudry
Journal:  Am J Physiol       Date:  1991-01
View more
  6 in total

1.  Onset of adreno-leukodystrophy after medulloblastoma therapy: causal connection or coincidence?

Authors:  G Deib; A Poretti; A Meoded; K J Cohen; G V Raymond; M Abromowitch; T A G M Huisman
Journal:  JIMD Rep       Date:  2011-09-06

2.  The use of a low dose hydrocortisone to prevent pulmonary embolism in patients with multiple trauma.

Authors:  Anis Chaari; Hatem Ghadhoune; Olfa Chakroune; Hanen Abid; Olfa Turki; Mabrouk Bahloul; Mounir Bouaziz
Journal:  Int J Clin Pharm       Date:  2013-04-21

3.  Interleukin-6 plasmatic levels in patients with head trauma and intracerebral hemorrhage.

Authors:  Alessandra Armstrong Antunes; Vanessa Santos Sotomaior; Keyth Suga Sakamoto; Cyro Pereira de Camargo Neto; Carolina Martins; Luiz Roberto Aguiar
Journal:  Asian J Neurosurg       Date:  2010-01

4.  Safety and efficacy of addition of hyaluronidase to a mixture of lidocaine and bupivacaine in scalp nerves block in elective craniotomy operations; comparative study.

Authors:  Ahmed Abdalla Mohamed; Tarek Ahmed Radwan; Mohamed Mahmoud Mohamed; Hatem Abdellatif Mohamed; Mohamed Farid Mohamed Elemady; Safinaz Hassan Osman; Tamer Fayez Safan; Tamer Mohamed Khair; Norhan Abdelaleem Ali; Rania Samir Fahmy; Mohamed Ibrahim Belita; Shady Rady Abdalla; Ahmed Abdelaziz Seleem; Ehab Mohi Atta; Osama Ismail Zaid; Ahmed Shaker Ragab; Ahmed Essam Salem; Badawy Mohamed AlKholy
Journal:  BMC Anesthesiol       Date:  2018-09-15       Impact factor: 2.217

5.  Anaesthesiological strategies in elective craniotomy: randomized, equivalence, open trial--the NeuroMorfeo trial.

Authors:  Giuseppe Citerio; Maria Grazia Franzosi; Roberto Latini; Serge Masson; Simona Barlera; Stefano Guzzetti; Antonio Pesenti
Journal:  Trials       Date:  2009-04-06       Impact factor: 2.279

6.  Effect of local anesthesia with lidocaine on perioperative proinflammatory cytokine levels in plasma and cerebrospinal fluid in cerebral aneurysm patients: Study protocol for a randomized clinical trial.

Authors:  Marijana Matas; Vlatka Sotošek; Ana Kozmar; Robert Likić; Ante Sekulić
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.